With full membership, watch our educational and editorial videos, search the site, receive our newsletters, join discussions, download slides and much more.
Hypertension affects approximately 73 million adults in the U.S. and is one of the most important risk factors for cardiovascular and renal diseases. Dr. Kountz will focus on current hypertension treatment disparities and high-risk patients while providing a thorough exploration of guideline-based management strategies.
Drs. Izzo and Ruilope discuss the importance of RAS inhibition in controlling hypertension to prevent or delay the development of MA in patients with diabetes.
Join Drs Giles, Elliott, Mason and White as they discuss a new approach to preservation of NO offered by the cyclooxygenase-inhibiting nitric oxide donating (CINOD) drugs, which may have an important role in treating arthritis patients with hypertension.
Read Dr. Kalaitzidis' review of the role of hypertension in the cardiovascular risk continuum, then watch Drs. Weber, Mancia, Williams, and Haller as they present the latest treatment options and preview important clinical trial data.
Microalbuminuria does not only signal worsening renal function but is an important marker in cardiovascular risk assessment. Join our expert panel, Drs. Izzo, Ruilope, and Weir as they discuss the interplay of diabetes and hypertension on the cardiovascular risk continuum.
Join Drs. Weber, Basile, and Gradman as they discuss methods of overcoming clinical inertia and strategies to ensure that more patients achieve their blood pressure goals.
Hypertension, hypercholesterolemia, insulin resistance, atherosclerosis, coronary heart disease, heart failure: are they all at the mercy of nitric oxide? Join Drs Weber, Cohn, Mason and Cockcroft in a discussion on the role nitric oxide plays in vascular health.
Drs. Izzo and Ruilope discuss the importance of RAS inhibition in controlling hypertension to prevent or delay the development of MA in patients with diabetes.
Read Dr. Kalaitzidis' review of the role of hypertension in the cardiovascular risk continuum, then watch Drs. Weber, Mancia, Williams, and Haller as they present the latest treatment options and preview important clinical trial data.
Hypertension affects approximately 73 million adults in the U.S. and is one of the most important risk factors for cardiovascular and renal diseases. Dr. Kountz will focus on current hypertension treatment disparities and high-risk patients while providing a thorough exploration of guideline-based management strategies.